Emerging markets are the developing economies of the world — fast-growing countries in Asia, Latin America, and Africa that are industrialising, urbanising, and building a middle class. The investment pitch is an attractive one: firms in these economies can grow far faster than their equivalents in the UK, Europe, or the US, and because their stock markets are out of favour much of the time, valuations are lower. The honest counterpoint is equally familiar: these markets can be brutally volatile, and over the last decade and a half they have on the whole disappointed.
This guide looks at where the opportunity actually lies, what can go wrong, and how a UK investor can sensibly hold a slice of emerging markets without taking on more risk than they can stomach.
Where the growth really is
The dominant names in emerging-market investing today are China and India, followed by Taiwan, South Korea, Brazil, South Africa, Mexico, and Indonesia. Each has its own character. India, the fastest-growing large economy, is riding young demographics and a rising workforce; China is the manufacturing powerhouse of the world but growing more slowly than in the past as its population ages; Taiwan and South Korea are technology hubs; Brazil and South Africa export commodities; Mexico benefits from its proximity to the US.
GDP growth figures for 2026 are estimates, but they give a sense of the spread. India is forecast to grow around 7%, Indonesia around 5%, China around 4.5%, Taiwan around 4%, South Korea around 3.5%, Brazil and Mexico around 3%, and South Africa around 2.5%. These rates leave the UK, Europe, and the US — typically 1-2% — well behind. The key nuance is that GDP growth does not automatically flow to shareholders. A company in a fast-growing country still has to convert that prosperity into earnings, and the hazards described below can easily destroy value instead.
Why invest in emerging markets at all
There are three defensible reasons to hold emerging markets, and they have little to do with predicting next year’s winner. The first is diversification: emerging-market stock prices have historically been less closely correlated with developed-market stock prices than the markets of similar economies, which means they can cushion a portfolio when Western markets stumble. The second is the structural story — billions of people are entering the consumer economy, and firms serving that rising demand have genuine room to expand. The third is valuation: emerging-market indices have historically traded at a discount to developed markets on price-to-earnings measures, offering the patient buyer a roughly cheaper entry point.
The diversification benefit deserves scrutiny, though. In a global sell-off — such as 2008 or the 2020 COVID crash — correlations rise and everything falls together. Emerging markets dilute your returns in a crisis just when you most want protection, and in a prolonged US bull market they can be the drag on your portfolio rather than the complement.
The risks, in plain English
Emerging-market investing comes with a distinct set of hazards that developed markets simply do not have. Currency risk is the most persistent: emerging-market currencies can weaken sharply against sterling and the dollar, wiping out gains made in local terms. In the 2008 crisis, the MSCI Emerging Markets index fell by roughly 53% against about 37% for US stocks — partly a currency effect, partly a valuation wipeout.
Political and regulatory risk is the hardest to quantify. Governments in some emerging markets can change the rules suddenly, nationalise industries, freeze capital, or restrict foreign investors. Corporate governance is another differentiator: shareholder protections are often weaker, minority investors can be treated poorly, and the quality of financial reporting can vary widely. Finally, liquidity risk — in smaller markets you may find it hard to exit a position quickly without moving the price against you. Weighing all of these, a long time horizon of a decade or more is a reasonable requirement before committing money to the asset class.
Performance: the uncomfortable history
The numbers tell a sobering story. In the 2003-2007 commodity and China boom years, the MSCI Emerging Markets index returned roughly +256% while the US S&P 500 returned about +82% — emerging markets more than tripled their developed-market rival. The 2008 crisis then hit them disproportionately hard at around -53%. The rebound of 2009-2010 was equally explosive, at roughly +106% versus +53% for the US. But from 2011 to 2020 the pattern reversed completely: the MSCI Emerging Markets index fell by roughly 15% while the S&P 500 gained around 180%, and the first half of the 2020s has been roughly flat by comparison.
| Period | MSCI Emerging Markets | S&P 500 |
|---|---|---|
| 2003-2007 | +256% | +82% |
| 2008 (crisis) | -53% | -37% |
| 2009-2010 | +106% | +53% |
| 2011-2020 | -15% | +180% |
| 2021-2025 | Roughly flat | +50%+ |
The lesson is not that emerging markets are doomed — the 2000s show they can be enormous winners. It is that periods of spectacular outperformance come around once or twice a generation, and in between they can lag for a decade or more. That is precisely why the asset class suits patient, diversified investors rather than people chasing last quarter’s figures.
How to invest: funds, not guesswork
For almost all investors, the right vehicle is a low-cost exchange-traded fund or index tracker that holds the whole emerging-market universe. The Vanguard VFEM ETF charges an ongoing cost of around 0.22%, the HSBC MSCI Emerging Markets tracker around 0.15%, and both give broad exposure from a single holding. Country-specific ETFs such as EWZ (Brazil) or EWH (Hong Kong) cost more — typically 0.50-0.60% — and concentrate your risk into one country’s politics, which is the opposite of what you want here. Actively managed emerging-market funds, such as Fundsmith Emerging Markets at around 1.0%, are available, but the higher fee is a real hurdle that the fund has to overcome.
Picking individual emerging-market stocks is best left to those with expertise and on-the-ground research. The information advantage a local investor has over you is large, and the governance and currency risks are exactly the things that are hardest to assess from a spreadsheet. Buy the fund, not the countries.
Getting the allocation right
Most global equity funds — such as VWRP, which holds both developed and emerging markets — already contain roughly 10-12% emerging markets. That is a healthy baseline, and many investors who own a single global tracker already have sensible exposure. If you buy a dedicated emerging-markets fund on top, a common guide is 5-10% of your portfolio for a conservative investor, 10-15% balanced, and 15-25% aggressive. The exact figure matters less than the discipline of rebalancing back to it, so that you are systematically selling high and buying low in a volatile asset class.
Watch: China and the dollar
Two forces will shape your returns. The first is China, which makes up around 30% of emerging-market indices. What matters for shareholders there is not always the long-term growth story but regulatory risk — the tech crackdowns that wiped out billions of market value in a matter of months are a reminder that policy can decimate entire sectors overnight. If China’s weight makes you uncomfortable, a China-light or China-excluded fund is a reasonable customisation, though you are deliberately deviating from global market proportions.
The second force is the US dollar. A strong dollar typically pressures emerging markets, because much of their debt is dollar-denominated and their currencies weaken in the process; a weak dollar generally helps. Keep an eye on the dollar, commodity prices, and — since many emerging-market economies are commodity exporters — the direction of energy and metals. Combined with local elections and interest-rate cycles, these are the levers that move the asset class.
Bottom line
Emerging markets remain a legitimate part of a diversified portfolio, but the case for them is patience and breadth, not excitement. They offer genuinely faster-growing economies, cheaper valuations, and useful diversification — and they can lag for a decade between bursts of spectacular performance. For a UK investor, the sensible expression is a modest allocation through a low-cost fund such as VFEM or an HSBC tracker, held inside an ISA where possible, reviewed alongside a global tracker that may already provide the exposure. Pick a percentage you can hold through a 40% decline, set your automatic contributions, and plan for a ten-year horizon. That is the only way this asset class has historically rewarded its holders.